1. Home
  2. ENTX vs WSBK Comparison

ENTX vs WSBK Comparison

Compare ENTX & WSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • WSBK
  • Stock Information
  • Founded
  • ENTX 2010
  • WSBK 2024
  • Country
  • ENTX Israel
  • WSBK United States
  • Employees
  • ENTX N/A
  • WSBK N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • WSBK
  • Sector
  • ENTX Health Care
  • WSBK
  • Exchange
  • ENTX Nasdaq
  • WSBK NYSE
  • Market Cap
  • ENTX 104.0M
  • WSBK 86.4M
  • IPO Year
  • ENTX 2018
  • WSBK N/A
  • Fundamental
  • Price
  • ENTX $1.94
  • WSBK $9.35
  • Analyst Decision
  • ENTX Strong Buy
  • WSBK
  • Analyst Count
  • ENTX 1
  • WSBK 0
  • Target Price
  • ENTX $10.00
  • WSBK N/A
  • AVG Volume (30 Days)
  • ENTX 35.9K
  • WSBK 74.6K
  • Earning Date
  • ENTX 05-09-2025
  • WSBK 01-01-0001
  • Dividend Yield
  • ENTX N/A
  • WSBK N/A
  • EPS Growth
  • ENTX N/A
  • WSBK N/A
  • EPS
  • ENTX N/A
  • WSBK 0.02
  • Revenue
  • ENTX $223,000.00
  • WSBK $15,687,000.00
  • Revenue This Year
  • ENTX N/A
  • WSBK N/A
  • Revenue Next Year
  • ENTX N/A
  • WSBK N/A
  • P/E Ratio
  • ENTX N/A
  • WSBK $568.59
  • Revenue Growth
  • ENTX N/A
  • WSBK N/A
  • 52 Week Low
  • ENTX $1.41
  • WSBK $8.91
  • 52 Week High
  • ENTX $2.79
  • WSBK $10.10
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 47.15
  • WSBK N/A
  • Support Level
  • ENTX $1.69
  • WSBK N/A
  • Resistance Level
  • ENTX $2.08
  • WSBK N/A
  • Average True Range (ATR)
  • ENTX 0.13
  • WSBK 0.00
  • MACD
  • ENTX -0.02
  • WSBK 0.00
  • Stochastic Oscillator
  • ENTX 58.14
  • WSBK 0.00

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About WSBK WINCHESTER BANCORP INC

Winchester Bancorp Inc provides a variety of financial services to individuals and small businesses through its offices in Winchester, Woburn, Danvers and Arlington, Massachusetts. Its primary deposit products are checking, savings and term certificate accounts and its primary lending products are residential and commercial real estate loans.

Share on Social Networks: